The Seiser group is funded by the Austrian Research Promotion Agency (FFG):
FFG Bridge Early stage project “Mimicking isoform-specific HDAC inhibitors” (5722451)
The Seiser group is funded by the Austrian Science Fund (FWF) through:
Stand alone Grants
P 37241-B ”Control of cutaneous lipid metabolism by enzymatic function of HDAC1” (2024-2027)
P 34998 "Epigenetic control of the innate immune system" (2021-2024)
P 28705 "Catalytic and non-catalytic functions of HDAC1 and HDAC2" (2016-2021)
P 28034 "HDAC1 and HDAC2 as regulators of tumorigenesis" (2016-2020)
The Seiser group is funded by the Austrian Science Fund (FWF) through a
Special Research program
SFB-F70: “HDACs as regulators of T cell-mediated immunity in health and disease”
The Seiser group is funded by the Austrian Science Fund (FWF) through Ph.D. Programs:
Doc.fund DOC 32 “Molecular & Cellular Control of Tissue Homeostasis in Health & Disease - TissueHome”
DK W1261 “Signaling Mechanisms in Cellular Homeostasis (SMICH)”